To assess the variation in expression of key components of the glycolytic pathway in ovarian cancers, expression levels of GLUT1, HKII, PKM2 and LDHA were investigated in a series of 380 ovarian tumours by Automated Quantitative Analysis (AQUA). This evidence concerns the gene SLC2A1 and ovarian carcinoma.